Compare NVEC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVEC | TECH |
|---|---|---|
| Founded | 1989 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.9M | 9.5B |
| IPO Year | 1996 | 1989 |
| Metric | NVEC | TECH |
|---|---|---|
| Price | $68.12 | $59.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $71.23 |
| AVG Volume (30 Days) | 59.3K | ★ 1.9M |
| Earning Date | 01-21-2026 | 02-04-2026 |
| Dividend Yield | ★ 5.96% | 0.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.85 | 0.49 |
| Revenue | $24,784,396.00 | ★ $1,216,732,000.00 |
| Revenue This Year | N/A | $2.33 |
| Revenue Next Year | N/A | $7.05 |
| P/E Ratio | ★ $23.56 | $119.71 |
| Revenue Growth | N/A | ★ 3.85 |
| 52 Week Low | $51.50 | $46.01 |
| 52 Week High | $88.50 | $79.28 |
| Indicator | NVEC | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 46.90 | 47.30 |
| Support Level | $70.12 | $56.84 |
| Resistance Level | $73.42 | $61.20 |
| Average True Range (ATR) | 2.47 | 2.03 |
| MACD | -0.08 | -0.36 |
| Stochastic Oscillator | 30.48 | 32.33 |
NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.